Home › Diffuse Scleroderma › Tennessee
Pag-aaral pangklinika para sa Diffuse Scleroderma sa Tennessee
4 pag-aaral para sa Diffuse Scleroderma ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Opisyal na teksto ng pag-aaral (English)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- West Tennessee Research Institute, Jackson
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06470048Platform Clinical Study for Conquering Scleroderma
- Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Hixson, Hixson
- Artiva Investigational Site Jackson, Jackson
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06991114The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- Vanderbilt University Medical Center, Nashville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT06675344Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.